Endocrinology & Metabolism

BMI alone may not be a sufficient indicator of metabolic health

Body mass index (BMI) is not a complete measure of metabolic health, and a high proportion of U.S. adults with normal BMI still have obesity, according to research being presented Friday at ENDO 2023, the Endocrine Society's ...

Medications

Maker of Wegovy limits supply of obesity drug in US

Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.

Health informatics

Dietary supplement use common in the United States

Dietary supplement (DS) use is common in the United States, according to a study published online April 18 in the National Health Statistics Reports, a publication from the U.S. Centers for Disease Control and Prevention.

Medications

Most US adults with T2D meet criteria for GLP-RAs, SGLT2is

Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10 percent use ...

page 2 from 33